Virax Biolabs Group Limited (VRAX) Total Assets by Year

VRAX

Virax Biolabs Group Limited closed fiscal year 2026 with $8.3M in total assets, $990K in total liabilities and $7.3M in shareholder equity. This represents an increase of 29.5% from the prior fiscal year. The table below carries 6 fiscal years, from 2021 to 2026, and the quarters Virax Biolabs Group Limited has filed alongside them.

FY2026 annual

Total Assets $8.3M

Total Liabilities $990K

Total Equity $7.3M

YoY +29.5%

5Y CAGR +191.4%

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Jul 2, 2026 Reported Jul 2, 2026 Currency USD

Annual figures, oldest first. Point at a bar to read its period.

VRAX Balance Sheet by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

Metric	FY2620-F	FY2520-F	FY2420-F	FY2320-F	FY2210-K	FY2110-K
Total Assets	$8.3M+29.5%	$6.4M+17.2%	$5.5M-44.1%	$9.8M+20046.2%	$49K+22.9%	$40K
Total Liabilities	$990K+2.6%	$965K+179.5%	$345K-62.0%	$908K-27.1%	$1.2M+42.9%	$871K
Total Equity	$7.3M+34.3%	$5.5M+6.3%	$5.1M-42.3%	$8.9M+844.0%	-$1.2M-43.9%	-$832K

VRAX Balance Sheet by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

Metric	Q3'2520-F	Q3'2420-F	Q3'2310-K	Q3'2210-Q	Q3'2110-K
Total Assets	$6.4M+17.2%	$5.5M-44.1%	$9.8M+20046.2%	$49K+22.9%	$40K
Total Liabilities	$965K+179.5%	$345K-62.0%	$908K-27.1%	$1.2M+42.9%	$871K
Total Equity	$5.5M+6.3%	$5.1M-42.3%	$8.9M+844.0%	-$1.2M-43.9%	-$832K

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More Virax Biolabs Group Limited financials

Frequently Asked Questions

What was Virax Biolabs Group Limited's total assets in fiscal year 2026?

Virax Biolabs Group Limited closed fiscal year 2026 with $8.3M in total assets, $990K in total liabilities and $7.3M in shareholder equity.

How fast is Virax Biolabs Group Limited's total assets growing?

Virax Biolabs Group Limited (VRAX) total assets rose by 29.5% year over year, from $6.4M to $8.3M in fiscal year 2026.

How has Virax Biolabs Group Limited's total assets changed over the years?

Across the 6 fiscal years this page covers, Virax Biolabs Group Limited (VRAX) total assets went from $40K in fiscal year 2021 to $8.3M in fiscal year 2026.

What was Virax Biolabs Group Limited's total assets in the most recent quarter?

Virax Biolabs Group Limited (VRAX) reported $6.4M in total assets in Q3 2025. This represents an increase of 17.2% from the same quarter a year earlier.

What does total assets mean on a financial statement?

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Virax Biolabs Group Limited (VRAX) reported on that line in every period on record.